Table 2.

Dose-Dependent Effects of PCB153 on Terminal Body, Body Weight Gain, Absolute Liver Weight and Relative Liver Weight at 24 h.

Dose (mg/kg)	Treatment	Terminal body weight (g)	Body weight gain	Liver weight (g)	Relative liver weight
0	Vehicle	11.8 ± 1.9	1.1 ± 0.0	0.694 ± 0.085	0.059 ± 0.006
1	PCB153	14.3 ± 1.8	1.1 ± 0.0	0.850 ± 0.121	0.059 ± 0.002
3	PCB153	14.4 ± 1.7	1.1 ± 0.0	0.865 ± 0.119	0.060 ± 0.002
10	PCB153	12.7 ± 1.1	1.1 ± 0.1	0.721 ± 0.073	0.056 ± 0.004
30	PCB153	13.4 ± 1.0	1.1 ± 0.0	0.836 ± 0.066	0.062 ± 0.001
100	PCB153	13.8 ± 1.1	1.1 ± 0.0	0.829 ± 0.071	0.060 ± 0.002
300	PCB153	12.7 ± 1.9	1.1 ± 0.0	0.855 ± 0.152	0.067 ± 0.003*

Values represent mean ± SD of five independent replicates. Body weight gain is represented as terminal body weight divided by body weight prior to dosing.

^(*)Asterisk indicates p<0.05 (PCB153 vs. vehicle).